NKTR News - Candlesense

Nektar Therapeutics to Participate in Two Investor Conferences in September

(NASDAQ:NKTR) SAN FRANCISCO, Sept. 3, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the company will be webcasting its participation in the H.C. Wainwright 27th Annua...

Conference

5 days ago

Nektar Therapeutics Reports Second Quarter 2025 Financial Results

SAN FRANCISCO, Aug. 7, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the second quarter ended June 30, 2025. Cash and investments in marketable securi...

How does this quarter’s performance affect the company's long‑term growth trajectory and potential M&A activity? What were the key operational highlights (e.g., trial enrollment, new partnership agreements) disclosed in the earnings release? How does NKTR’s cash position of $175.9 million compare to its cash runway and the need for additional financing?

Earnings

about 1 month ago